首页 | 本学科首页   官方微博 | 高级检索  
     

西地那非辅助治疗COPD合并肺心病的临床研究
引用本文:李怀东. 西地那非辅助治疗COPD合并肺心病的临床研究[J]. 中国误诊学杂志, 2010, 10(30): 7318-7319
作者姓名:李怀东
作者单位:解放军第八十八医院呼吸科,山东泰安271000
摘    要:目的观察西地那非辅助治疗COPD合并肺心病的临床疗效。方法将入选的COPD患者随机分为两组,对照组常规治疗,治疗组在其基础上加用西地那非25 mg/次,2次/d,1个月为1疗程。结果治疗组呼吸困难评分、血气、心脏射血分数、肺通气功能、平均肺动脉压力与对照组比较有统计学意义(P〈0.05)。结论西地那非可改善COPD合并肺心病患者心肺功能,显著降低肺动脉压力。

关 键 词:哌嗪类/治疗应用  肺疾病,慢性阻塞性/药物疗法/并发症  肺心病/药物疗法/并发症

Clinical Study on Sildenafil in Adjuvant Therapy of COPD Combined with Pulmonary Heart Disease
LI Huai-dong. Clinical Study on Sildenafil in Adjuvant Therapy of COPD Combined with Pulmonary Heart Disease[J]. Chinese Journal of Misdiagnostics, 2010, 10(30): 7318-7319
Authors:LI Huai-dong
Affiliation:LI Huai-dong.Department and Pneumology,No.88 Hospital of PLA,Tai'an 271000,China
Abstract:Objective To observe the clinical effect of sildenafil in adjuvant therapy of COPD combined with pulmonary heart disease.Methods The enrolled patients were divided into two groups.Control group received routine treatment,and therapy group received sildenafil 25 mg each time,twice a day,a month as a course of treatment based on routine treatment.Results The dyspnea grade、blood gas analysis、ejection fraction、pulmonary ventilation function and mean pulmonary artery pressure had statistical significances(P〈0.05) comparing therapy group and control group.Conclusion Sildenafil can improve cardio-pulmonary function of patients with COPD combined with pulmonary heart disease and decrease pulmonary artery pressure dramaticlly.
Keywords:Piperazine derivatives/therapeutic use  Pulmonary disease  Chronic obstructive/pharmacotherapy/complication  Pulmonary heart disease/pharmacotherapy/complication
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号